Mizuho Securities is a provider of personal information handling and money laundering prevention services... Read more
Mizuho Securities is a provider of personal information handling and money laundering prevention services... Read more
CEO
Add
News
Jun 17, 2020
Xconomy
Mizuho Securities Principal Investment: C4 Therapeutics Adds $170M to Test Protein Degraders in the Clinic
Jun 16, 2020
FirstWord Pharma
Mizuho Securities Principal Investment: C4 Therapeutics Raises $170 Million Financing to Bring Robust Pipeline of Protein Degraders to Clinical Proof-of-Concept and to Advance Proprietary Platform
Feb 27, 2020
DealStreetAsia
Mizuho Securities Principal Investment: Japanese VC I-nest Capital secures $60m for debut fund
Jul 24, 2019
FinSMEs
Mizuho Securities Principal Investment: Frequency Therapeutics Closes $62M Series C Financing